U.S. Communications Stock News

Immunome (IMNM) is back in focus after reporting successful Phase 3 data for its lead drug candidate, varegacestat, as well as plans to present at the upcoming J.P. Morgan Healthcare Conference, drawing fresh attention to the stock. See our latest analysis for Immunome. That backdrop helps explain why Immunome’s share price, now at $21.07, has seen a 90 day share price return of 51.36%, while the 1 year total shareholder return sits at 98.77%, suggesting momentum has been building around the...

In recent days, EverCommerce reported quarterly results that missed revenue expectations and led management to lower full-year guidance, even as the company achieved profitability and outperformed on adjusted EBITDA, while President Matthew Feierstein continued his pattern of selling 25,000 shares in open-market transactions. At the same time, EverCommerce acquired AI platform ZyraTalk to bolster its SaaS capabilities and expanded its share repurchase authorization by US$50.00 million,...

Haoxin Holdings Limited ( NASDAQ:HXHX ) shareholders are no doubt pleased to see that the share price has bounced 31...

Key Insights Institutions' substantial holdings in Lexeo Therapeutics implies that they have significant influence over...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Despite an already strong run, Bridger Aerospace Group Holdings, Inc. ( NASDAQ:BAER ) shares have been powering on...

Key Insights The projected fair value for Legacy Housing is US$27.17 based on 2 Stage Free Cash Flow to Equity Current...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

Zeta Global Holdings Corp. ( NYSE:ZETA ) shares have continued their recent momentum with a 25% gain in the last month...

With a price-to-sales (or "P/S") ratio of 10.5x CeriBell, Inc. ( NASDAQ:CBLL ) may be sending very bearish signals at...

Ubiquiti Inc. ( NYSE:UI ) saw significant share price movement during recent months on the NYSE, rising to highs of...

Black Diamond Therapeutics (NASDAQ:BDTX) has had a rough three months with its share price down 31%. However, a closer...

Waldencast plc ( NASDAQ:WALD ) shareholders won't be pleased to see that the share price has had a very rough month...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Unfortunately for some shareholders, the NextNRG Inc. ( NASDAQ:NXXT ) share price has dived 30% in the last thirty...

We feel now is a pretty good time to analyse Wallbox N.V.'s ( NYSE:WBX ) business as it appears the company may be on...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Smith Douglas Homes fair value estimate is US$20.42 With...

To the annoyance of some shareholders, Fangdd Network Group Ltd. ( NASDAQ:DUO ) shares are down a considerable 30% in...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Mobile Infrastructure fair value estimate is US$2.10 Mobile...

Coverage of Phreesia (PHR) has picked up as Wells Fargo and RBC Capital recently issued positive ratings, bringing fresh attention to how its patient intake platform and profitability plans compare with the current share price. See our latest analysis for Phreesia. Recent positive coverage arrives after a mixed run for shareholders, with a 9.19% 1 month share price return and 5.71% year to date share price return, set against a 35.42% 1 year total shareholder return decline and weaker longer...

The BellRing Brands, Inc. ( NYSE:BRBR ) share price has fared very poorly over the last month, falling by a substantial...

Orion S.A. ( NYSE:OEC ) shareholders should be happy to see the share price up 16% in the last month. Meanwhile over...

Key Insights Given the large stake in the stock by institutions, Sabre's stock price might be vulnerable to their...